Chad Roy at the Tulane National Primate Research Center is participating in a three-center study of an antiviral drug for the treatment of smallpox, which has re-emerged as a possible bioterrorism weapon. (Credit: Robin Rodriguez)
TULANE (US)—A nationwide effort is under way to develop an inhaled version of an antiviral drug to treat smallpox, a disease that was eradicated worldwide in the 1970s but one that has re-emerged as a possible bioterrorism weapon.